TABLE 1.
Relationship between breakpoint MIC and MIC for each test strain
| Antibiotic | BkPta (μg/ml) | LAC |
UAMS-1 |
||
|---|---|---|---|---|---|
| MIC (μg/ml) | Ratio (MIC/BkPt) | MIC (μg/ml) | Ratio (MIC/BkPt) | ||
| Vancomycin | 2.0 | 2.0 | 1.0 | 1.5 | 0.75 |
| Daptomycin | 1.0 | 0.5 | 0.5 | 0.5 | 0.5 |
| Ceftaroline | 1.0 | 0.5 | 0.5 | 0.5 | 0.5 |
| Tigecycline | 0.5 | 0.125 | 0.25 | 0.19 | 0.38 |
| Telavancin | 0.12 | 0.047 | 0.39 | 0.047 | 0.39 |
| Oxacillin | 2.0 | 128 | 64 | 1.5 | 0.75 |
a
BkPt, breakpoint MIC. The breakpoint MICs cited are those defined by the United States Food and Drug Administration (FDA) for a susceptible strain of S. aureus.